Details for Patent: 5,965,581
✉ Email this page to a colleague
Summary for Patent: 5,965,581
Title: | Compositions for inhibiting platelet aggregation |
Abstract: | A composition is disclosed comprising about 0.25 mg/ml 2-S-(n-Butylsulfonylamino)-3 -[4-(4-(piperdin-4-yl)butyloxylphenyl]propionic acid, about 8 mg/ml sodium chloride, about 2.7 mg/ml sodium citrate dihydrate, about 0.16 mg/ml citric acid anhydrous, wherein the composition osmolality concentration is between about 250-310 mOsmol/kg and the pH is in the range of between 5.5-6.5. |
Inventor(s): | Gelotte; Karl M. (North Wales, PA) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 09/079,776 |
Patent Claim Types: see list of patent claims | Composition; Compound; Use; |
Drugs Protected by US Patent 5,965,581
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,965,581
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 004223 | ⤷ Try a Trial | |||
Austria | 213648 | ⤷ Try a Trial | |||
Australia | 712755 | ⤷ Try a Trial | |||
Australia | 7718996 | ⤷ Try a Trial | |||
Bulgaria | 102405 | ⤷ Try a Trial | |||
Bulgaria | 63623 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |